Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000808

Director sold 17,989 shares at $18.53 ($333,336)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-22 Sale : show line 1 in the form −10,954 $18.53 $202,978 2,069,186 I
2017-08-23 Sale : show line 2 in the form −7,035 $18.53 $130,359 2,062,151 I
Open-market sales · 17,989 sh · avg $18.53 · $333,336
Loading xslF345X03/vonemster_fm4aug222017.xml…